| Q37449779 | A review on the biological properties of C-reactive protein |
| Q34434076 | Ambient particulate matter, C-reactive protein, and coronary artery disease |
| Q26822655 | Atherosclerosis: process, indicators, risk factors and new hopes |
| Q38931129 | Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns. |
| Q90441319 | C-Reactive Protein and Its Structural Isoforms: An Evolutionary Conserved Marker and Central Player in Inflammatory Diseases and Beyond |
| Q44141714 | C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes |
| Q46708458 | C-reactive protein and C1q regulate platelet adhesion and activation on adsorbed immunoglobulin G and albumin |
| Q26860959 | C-reactive protein and coronary heart disease: all said--is not it? |
| Q41018619 | C-reactive protein and the acute phase reaction in geriatric patients |
| Q37949270 | C-reactive protein as a biomarker for urological cancers |
| Q39157793 | C-reactive protein in patients with lymphatic filariasis: increased expression on lymphocytes in chronic lymphatic obstruction |
| Q69023792 | C-reactive protein is involved in natural killer cell-mediated lysis but does not mediate effector-target cell recognition |
| Q45174694 | C-reactive protein: history and revival |
| Q37300823 | Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis |
| Q34778126 | Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: an integrated DTI study |
| Q55303250 | Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes. |
| Q40394846 | Expression of C-reactive protein in human lung epithelial cells and upregulation by cytokines and carbon particles |
| Q39518908 | Expression of C-reactive protein in the human respiratory tract |
| Q36229839 | Extrahepatic transcription of human C-reactive protein. |
| Q34683905 | Genes and abdominal aortic aneurysm |
| Q40822344 | High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib. |
| Q84607779 | Human gingiva is another site of C‐reactive protein formation |
| Q74291846 | Immunohistochemical distribution of C-reactive protein in the hepatic tissue in forensic autopsy |
| Q33930080 | Inducible and tissue-specific expression of human C-reactive protein in transgenic mice |
| Q37838426 | Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke |
| Q42909180 | Interpretation of C-reactive protein concentrations in critically ill patients |
| Q48154622 | Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder |
| Q36648028 | Linking C-reactive protein to late-life disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002. |
| Q37203184 | Local C-reactive protein expression in obliterative lesions and the bronchial wall in posttransplant obliterative bronchiolitis |
| Q72567643 | Membrane-associated C-reactive protein on rat liver macrophages is synthesized within the macrophages, expressed as neo-C-reactive protein and bound through a C-reactive protein-specific membrane receptor |
| Q33683165 | Modified C-Reactive Protein Might be a Target Autoantigen of TINU Syndrome |
| Q89400335 | Neuropil pruning in Early-Course Schizophrenia: Immunological, Clinical, and Neurocognitive Correlates |
| Q36897456 | New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor |
| Q38344796 | Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis |
| Q28645842 | Proinflammatory cytokines in CRP baseline regulation |
| Q35213253 | Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis |
| Q38035035 | Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes |
| Q44935758 | Serum C-reactive protein levels in postmortem blood--an analysis with special reference to the cause of death and survival time |
| Q38584193 | Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification |
| Q26999377 | Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes |
| Q90259218 | The Effect of C-Reactive Protein Isoforms on Nitric Oxide Production by U937 Monocytes/Macrophages |
| Q37733630 | The Potential Role of Aerobic Exercise-Induced Pentraxin 3 on Obesity-Related Inflammation and Metabolic Dysregulation |
| Q43248101 | The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates |
| Q92860700 | The effects of levosimendan use on high-sensitivity C-reactive protein in patients with decompensated heart failure |
| Q83476372 | Tumoral CRP expression in thoracic esophageal squamous cell cancers is associated with poor outcomes |